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With the considerable advances that have been made in the
development of potent and effective drugs, it is unfortunate
that in many situations drugs are not being optimally utilised.
Non-compliance is a major cause of ineffective therapy and it
adds considerably to the medicine bill in South Africa.
I)atients cannot be coerced, frightened, threatened or cajoled
intO compliance. They can, however, be educated, advised and
encouraged. It is essential that the compliant patient sees
hinlseIf as an active member of the medication team, not the
passive victim of disease. 10
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Vertically transmitted HIV-l infection in children
A report of 23 cases
I. R. FRIEDLAND, M. SNIPELlSKY
Summary
Twenty-three children with vertically transmiUed human
immunodeficiency virus type 1 (HIV-1) infection were seen at
Baragwanath Hospital between May 1989 and April 1990.
There was a marked increase in the number of cases in 1990.
Infected children presented at a median age of 6 months;
most commonly with lymphadenopathy, failure to thrive and
respiratory complications. Serious bacterial infections
occurred in 39%. Reversed helper T- to suppressor T-cell
ratios were present in all but 1 of 16 children tested and
hypergammaglobulinaemia and anaemia (usually normocytic)
were frequently present. Some of the children have already
died and the outlook for the others is bleak. With the increase
of HIV infection in the heterosexual population, increasing
numbers of infected children can be expected.
S Atr Med J 1991; 79: 157-159.
The prevalence of human immunodeficiency virus type 1
(HIV-l) infection is increasing in South AfricaY The HIV
seroprevalence rate in antenatal clinic attenders in Soweto has
increased from 0,31%during the period March - October 1988
to 0,49% during May - October 1989 (South African Institute
for Medical Research (SAIMR), Baragwanath Hospital -
unpublished data). With the increased number of infected
women of child-bearing age the number of vertically infected
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children can be expected to increase similarly. We report 23
cases that have been diagnosed at Baragwanath Hospital since
our first case in May 1989.
Patients and methods
The clinical and laboratory records of 23 infants diagnosed as
having vertically transmitted HIV infection were reviewed.
The children were tested for HIV on the basis of suspicious
clinical features. Enzyme-linked immunosorbent assay (ELISA)
serology (Abbott Recombinant HIV-l/HIV-2 EIA) was posi-
tive and this was confirmed by Western blot (SAIMR in-
house transblotting; HIV-1 virolysate with commercial con-
trols - Organon-Technika, Durham, NC, USA). All the
mothers of the children were HIV-antibody positive, indicating
mother-to-infant transmission. Antigen testing was not per-
formed. T-cell subsets were performed using a Facscan Flow
Cytometer (Becton Dickinson, Mountainview, California,-
USA).
Results
The incidence of cases of vertically transmitted HIV infection
diagnosed, over the 12-month period from May 1989 is shown
in Fig. 1. In the first 4 mODths of 1990 16 cases were
diagnosed, representing 1,2% of admissions to the paediatric
wards of Baragwanath Hospital. The median age of onset of
symptoms was 4 months (range 19 days - 15 months) and the
median age at diagnosis 6 months (range 20 days - 43 months).
Eighteen of the children were male (78%). At the time of
writing, 9 of the children are known to have died (median time
from onset of symptoms to death 2 months), 7 are known to be
alive and the rest have been lost to follow-up.
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Fig. 1. Vertically transmitted HIV infection, Baragwanath Hospital,
May 1989 - April 1990.
TABLE I. CLINICAL FEATURES ON PRESENTATION OF 23
HIV-INFECTED CHILDREN
Viral infections
Viral bronchopneumonia was confIrmed in 2 cases. One had
serological evidence of influenza type B and measles virus was
isolated from a tracheal aspirate of the other. This child was 1
month old, had no skin rash and died of respiratory failure.
One child was positive for hepatitis B surface antigen (and e
antigen) and cytomegalovirus was grown from the urine of 2
other children.
The HIV ELISA and Western blot tests were positive in all
23 infants and their mothers. Of 10 fathers, who were tested
soon after the presentation of their children, 5 were HIV-
positive. There was some evidence of abnormal immune func-
tion in all the children. T -cell subsets were performed in 16
children and 15 of these were abnormal. Fourteen of these 15
cases had raised immunoglobulin G (IgG). Thus 14/16 patients,
in whom tests of both cellular and humoral immunity were
performed, fulfilled the US Centers for Disease Control (CDq
criteria for HIV infection in children under 15 months of age. 3
The 7 patients, who did not have tests of cellular immunity, all
had raised IgG levels. .
Details of laboratory and radiological fIndings are presented
in Table 11. Total lymphopenia was rare. Fifteen of 16 children
had reversed helper T - to suppressor T-cell ratios (i.e. T4/T8
< 1) but only 4 had absolute T4 counts of < 1000 X 106/1. Of
the children known to have died, only 1 had a low T4 count.
All children tested (N = 17) had elevated levels of .B2-micro-
globulin. Most of the children were an,aemic; 30% had micro-
cytosis (with low serum iron) and the rest normocytic anaemia.
Lung infiltrates were seen in 70% of children of whom only
63% had signs of respiratory distress. The causes of these
infiltrates were not. determined in most cases but it was
suspected that many of these were due ·to lymphoid interstitial
pneumonitis (LIP). In some cases there was clinical improve-
ment with standard antibiotic treatment, although the lung
infiltrates rarely improved.
Mar-Apr
separate episodes caused by Staphylococcus aureus, Salmonella
sp. and Shigella), lobar pneumonia in 2 (1 of whom grew
Screptococcus pneumoniae on blood culture), prolonged or recur-
rent suppurative otitis media in 3 (1 of whom was only 20 days
-------1 old) and 1 child with recurrent meningitis (Haemophilus
injluenzae type b) and recurrent septicaemia (H. injluenzae and
S. pneumom·ae). Mycobaceenum cuberculosis was isolated from a




At least one of the parents of 5 children originated from
beyond South Africa (viz. Zimbabwe, Malawi and Mozam-
bique). The parents of 7 children were Soweto or Johannesburg
residents. The rest of the parents came from other parts of
South Africa, mostly Natal.
The clinical features present at the time of diagnosis are
shown in Table 1. The most common presenting features were
failure to thrive and lymphadenopathy. Although some of the
children did not have lymph nodes> 1 cm in size they were
thought to have increased numbers in and involvement of
unusual sites, such as epitrochlear and axillary areas. This was'
noted before the diagnosis of HIV was confirmed. Neuro-
developmental abnormalities were noted in 7 infants; 4 had
developmental delay, 2 were abnormally floppy and 1 had
developmental delay and was spastic. Four cases presented
with 'mild' kwashiorkor and HIV infection was suspected
because of wasting and lymphadenopathy. No cases of Pneumo-
cyscis cannii pneumonia were diagnosed. However, tracheal
aspirates were obtained in only a few children and no children




* Above/below the limits of normal for age.




6,7 0,3 - 15,2
1299 10 - 2639
0,3 0,01 - 1,4
4,6 3,1 - 6,1
TABLE 11. LABORATORY AND RADIOLOGICAL FEATURES








White cell count> 15,0 X 109 /1
Anaemia*
Haemoglobin < 8 g/dl






Lymphocytes (X 109 /1)
Helper T cells (X 106 /1)
Helper T/suppressor T cells (T4/T8)
Beta 2-microglobulin (mg/l)
(normal < 3 mg/l)
No. present %
Lymphadenopathy 19 83




Oral thrush 15 65
Diarrhoea 15 65
Splenomegaly 13 57




Neurodevelopmental abnormalities 7 30
Seborrhoeic dermatitis 3 13
Dysmorphism 3 13
.. Includes 4 infants with kwashiorkor.
Bacterial infections
Nine of the children (39%) presented with serious bacterial
infections. These included septicaemia in 3 (l had three
-
Discussion
After the first diagnosed case of vertically transmined HIV-l
infection in May 1989, a dramatic increase has been seen in
the number of HIV-infected infants at Baragwanath Hospital.
This is due partly to a true increase in incidence but also
pgrtly to an increased awareness of the illness in our department
aDd consequently an increased number of children being
tested.
Because of the transplacental transfer of antibodies, which
can persist for up to 12 - 15 months/,4 the confIrmation of
infection in infants below this age can be problematical. The
CDC has laid down criteria for the diagnosis of HIV infection
in children.3 For children under 15 months of age all three of
the following criteria should be fulfilled: (I) positive HIV
serology; (il) typical symptoms; and (iil) laboratory abnormali-
ties of both cellular and humoral immunity. Where tested,
most of the children in our study fulfilled these criteria.
However, 2/16 children had abnormalities of either cellular or
humoral immunity but not both and thus did not fulfil the
third-mentioned criterion. In our earlier cases T-cell subsets
were not performed but all these children had evidence of
abnormal humoral immunity (hypergammaglobulinaemia and!
or raised IgG). We are of the opinion that abnormalities of
either humoral or cellular immunity together with the fIrst two
criteria mentioned above are adequate evidence of HIV infec-
tion. This is particularly relevant in areas where T-cell function
tests are not available.
The children in this series usually presented under the age
of I year (median 6 months). Only I child was over 2 years at
the time of diagnosis. This is in keepinr with experienceelsewhere.5- 7 In a large study from Miami, in which children
were followed up from birth, 57% of children presented,at < I
year and 23% at > 2 years of age. Our cases were of a younger
age than in this report but the mean age of onset in any area
can be expected to increase with time.8,9 The marked pre-
ponderance of male infants in this series is unexplained.
The most common presenting features in our children were
lymphadenopathy, failure to thrive and respiratory sympto-
matology. This is similar to other studies.5- 7,lo We have been
especially impressed with the frequency of lymphadenopathy,
not only because of the size of the lymph nodes but more
because of their number and location. The finding of epi-
trochlear and numerous axillary glands (in addition to numerous
inguinal and cervical lymph nodes) was common.
Serious bacterial infections were also relatively common and
included septicaemia, meningitis, lobar pneumonia and sup-
purative otitis media. This last rmding is not included in the
CDC defInition of serious bacterial infections3 but we have
included these cases because they were persistent or occurred
at a very young age. Lung infIltrates were often present and,
although we suspect that most of these were due to LIP, this
was not histologically proven.
Four patients presented with kwashiorkor, which was
thought to be 'mild', and because of signifIcant lymphadeno-
pathy and wasting HIV infection was suspected. One can
speculate as to whether the kwashiorkor in these cases was
primarily nutritional or was precipitated by the HIV infection.
The most frequently abnormal laboratory investigations were
reversal of the helper T-/suppressor T -cell ratio, and elevated
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,82-microglobulin and IgG levels. Low absolute helper T -cell
numbers and total lymphopenia were uncommon even in
children who subsequently died. Other common laboratory
abnormalities included hypergammaglobulinaemia and normo-
cytic anaemia. These findings are typical,s,7,11,12 but anaemia,
although common,13 is often not emphasised.
Once illness has manifested itself, the prognosis is extremely
bleak. Studies with a longer follow-u~ r~rt a median survival
after presentation of 9 - 38 months. 8, 4-1 Our follow-up period
is at present too short to determine life expectancy but a
number of the infants died within 2 months of presentation.
Based on our experience, we recommend that HIV testing
be performed on any child who has any of the following
conditions that is otherwise unexplained: (I) generalised lymph-
adenopathy; (il) hepatosplenomegaly; (iil) failure to thrive; (iv)
recurrent or persistent respiratory 'infection'; (v) severe or
recurrent oral thrush; (m) recurrent serious bacterial infections;
and (vii) hypergammaglobulinaemia or raised IgG levels.
HIV infection is on the increase in South Mrica and we
hope this report will heighten awareness and recognition of
this infection in children.
The authors wish to thank Professor J. Penifor for reviewing
the manuscript. The ongoing srudy of HIV-infected children at
Baragwanath Hospital is supported by the South African Medical
Research Council.
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